Please assess the completion status of the following clinical trial:

Trial Title: Ketamine and Magnesium in Post-operative Pain Control in Patients Treated With Opioids

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE1
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. Subjects undergoing elective laparoscopic gynecologic surgery~2. Patients with chronic pelvic pain defined as pain that has persisted for more than 6 months in duration which is localized to the pelvis, anterior abdominal wall, lower back or buttocks and has leads to functional disability or medical care1~3. Patients requiring opioids daily for \>1 month~4. Consenting adults age 18-80~5. American Society of Anesthesiologists (ASA) Physical Status classification II to ASA III~Exclusion Criteria:~1. Patient refusal~2. Chronic Kidney disease (Creatinine\>2)~3. Patients treated with methadone~4. Known allergy or adverse effect of ketamine or magnesium~5. Patient unable to give informed consent~6. Patient with limited or no English fluency~7. Uncontrolled hypertension

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: 80 Years
- Healthy Volunteers: f

Study Arms:
- Ketamine plus Magnesium sulfate (Type: ACTIVE_COMPARATOR): Ketamine 0.5mg/kg IV dose with 2g magnesium IV dose
- Placebo (Type: PLACEBO_COMPARATOR): Normal Saline (NaCl 0.9%)

Based on this trial design, predict the completion outcome and termination type (if applicable).